bioMérieux Statistics

Total Valuation

bioMérieux has a market cap or net worth of EUR 13.73 billion. The enterprise value is 13.77 billion.

Market Cap	13.73B
Enterprise Value	13.77B

Important Dates

The last earnings date was Friday, March 14, 2025.

Earnings Date	Mar 14, 2025
Ex-Dividend Date	Jun 9, 2025

Share Statistics

bioMérieux has 117.93 million shares outstanding. The number of shares has decreased by -0.06% in one year.

Current Share Class	n/a
Shares Outstanding	117.93M
Shares Change (YoY)	-0.06%
Shares Change (QoQ)	+0.24%
Owned by Insiders (%)	0.05%
Owned by Institutions (%)	18.64%
Float	43.65M

Valuation Ratios

The trailing PE ratio is 31.98 and the forward PE ratio is 25.69. bioMérieux's PEG ratio is 2.02.

PE Ratio	31.98
Forward PE	25.69
PS Ratio	3.44
PB Ratio	3.26
P/TBV Ratio	4.60
P/FCF Ratio	42.70
P/OCF Ratio	n/a
PEG Ratio	2.02

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 14.03, with an EV/FCF ratio of 42.84.

EV / Earnings	31.87
EV / Sales	3.46
EV / EBITDA	14.03
EV / EBIT	21.59
EV / FCF	42.84

Financial Position

The company has a current ratio of 2.20, with a Debt / Equity ratio of 0.12.

Current Ratio	2.20
Quick Ratio	1.22
Debt / Equity	0.12
Debt / EBITDA	0.50
Debt / FCF	1.53
Interest Coverage	39.87

Financial Efficiency

Return on equity (ROE) is 10.68% and return on invested capital (ROIC) is 8.89%.

Return on Equity (ROE)	10.68%
Return on Assets (ROA)	7.23%
Return on Invested Capital (ROIC)	8.89%
Return on Capital Employed (ROCE)	13.76%
Revenue Per Employee	275,407
Profits Per Employee	29,908
Employee Count	13,982
Asset Turnover	0.72
Inventory Turnover	1.81

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +14.82% in the last 52 weeks. The beta is 0.24, so bioMérieux's price volatility has been lower than the market average.

Beta (5Y)	0.24
52-Week Price Change	+14.82%
50-Day Moving Average	114.92
200-Day Moving Average	104.58
Relative Strength Index (RSI)	54.37
Average Volume (20 Days)	134,702

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, bioMérieux had revenue of EUR 3.98 billion and earned 432.20 million in profits. Earnings per share was 3.64.

Revenue	3.98B
Gross Profit	2.22B
Operating Income	637.90M
Pretax Income	579.40M
Net Income	432.20M
EBITDA	948.20M
EBIT	637.90M
Earnings Per Share (EPS)	3.64

Full Income Statement

Balance Sheet

The company has 449.80 million in cash and 490.70 million in debt, giving a net cash position of -40.90 million or -0.35 per share.

Cash & Cash Equivalents	449.80M
Total Debt	490.70M
Net Cash	-40.90M
Net Cash Per Share	-0.35
Equity (Book Value)	4.21B
Book Value Per Share	35.66
Working Capital	1.37B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 667.30 million and capital expenditures -345.80 million, giving a free cash flow of 321.50 million.

Operating Cash Flow	667.30M
Capital Expenditures	-345.80M
Free Cash Flow	321.50M
FCF Per Share	2.73

Full Cash Flow Statement

Margins

Gross margin is 55.66%, with operating and profit margins of 16.03% and 10.86%.

Gross Margin	55.66%
Operating Margin	16.03%
Pretax Margin	14.56%
Profit Margin	10.86%
EBITDA Margin	23.82%
EBIT Margin	16.03%
FCF Margin	8.08%

Dividends & Yields

This stock pays an annual dividend of 0.90, which amounts to a dividend yield of 0.77%.

Dividend Per Share	0.90
Dividend Yield	0.77%
Dividend Growth (YoY)	5.88%
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.06%
Shareholder Yield	0.83%
Earnings Yield	3.15%
FCF Yield	2.34%

Dividend Details

Stock Splits

The last stock split was on September 20, 2017. It was a forward split with a ratio of 3.

Last Split Date	Sep 20, 2017
Split Type	Forward
Split Ratio	3

Scores

bioMérieux has an Altman Z-Score of 5.99.

Altman Z-Score	5.99
Piotroski F-Score	n/a